Complete Filing Data
GENMAB A/S reported Cash And Cash Equivalents of $1.72 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GENMAB A/S did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Profit Loss | $963.0M | $1.13B | $4.35B | $2.17B | $1.47B | $1.10B |
| Comprehensive Income | $1.01B | $909.0M | $770.0M | $2.17B | $1.48B | $1.08B |
| Research And Development Expense | $1.61B | $1.41B | $1.11B | $2.39B | $1.43B | $874.0M |
| Profit Loss From Operating Activities | $1.07B | $972.0M | $772.0M | $2.64B | $1.38B | $1.34B |
| Profit Loss Before Tax | $1.20B | $1.33B | $817.0M | $2.86B | $1.61B | $1.06B |
| Income Tax Expense Continuing Operations | $241.0M | $193.0M | $186.0M | $693.0M | $140.0M | -$40.0M |
| Adjustments For Income Tax Expense | -$460.0M | -$50.0M | -$155.0M | -$476.0M | $46.0M | -$181.0M |
| Other Comprehensive Income | $45.0M | -$224.0M | $139.0M | $6.0M | $10.0M | -$21.0M |
| Selling General And Administrative Expense | $626.0M | $549.0M | $478.0M | |||
| Other Comprehensive Income Before Tax Exchange Differences On Translation | $45.0M | -$224.0M | $139.0M | |||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $6.0M | $10.0M | -$17.0M | |||
| General And Administrative Expense | $342.0M | $214.0M | $147.0M | |||
| Cost Of Sales | $238.0M | $143.0M | $33.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $1.72B | $1.38B | $2.20B | $1.42B | $3.55B | $533.0M | $1.35B | $307.0M |
| Cash Flows From Used In Operating Activities | $1.19B | $1.13B | $1.07B | $1.33B | $1.02B | $1.59B | ||
| Cash Flows From Used In Investing Activities | -$5.64B | -$9.91B | -$185.0M | -$1.98B | -$1.78B | -$668.0M | ||
| Cash Flows From Used In Financing Activities | $4.79B | -$3.92B | -$606.0M | $3.66B | -$71.0M | $215.0M | ||
| Rightofuse Assets | $127.0M | $128.0M | $102.0M | $75.0M | $177.0M | $205.0M | ||
| Purchase Of Investments Other Than Investments Accounted For Using Equity Method | $991.0M | $1.25B | $1.58B | $5.81B | $3.52B | $3.43B | ||
| Increase Decrease Through Exercise Of Warrants Equity | $23.0M | $19.0M | $21.0M | $65.0M | $75.0M | $215.0M | ||
| Cash Flow From Used In Operating Activities Before Financial Items | $1.52B | $1.05B | $1.10B | $1.71B | $925.0M | $1.73B | ||
| Liabilities | $7.03B | $9.11B | $545.0M | $1.10B | $447.0M | |||
| Assets | $12.87B | $45.81B | $35.29B | $15.14B | $8.46B | |||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $37.0M | $27.0M | $53.0M | $79.0M | $72.0M | $89.0M | ||
| Noncurrent Lease Liabilities | $134.0M | $131.0M | $101.0M | $155.0M | ||||
| Current Lease Liabilities | $18.0M | $13.0M | $13.0M | $26.0M | ||||
| Adjustments For Interest On Lease Payments | -$5.0M | -$5.0M | -$3.0M | -$7.0M | ||||
| Trade And Other Current Receivables | $1.11B | $923.0M | $733.0M | $2.99B | $1.33B | |||
| Retained Earnings | $4.10B | $3.39B | $2.74B | $2.13B | -$198.0M | |||
| Noncurrent Assets | $9.99B | $2.51B | $320.0M | $1.18B | $1.03B | |||
| Equity And Liabilities | $12.87B | $6.41B | $5.23B | $15.14B | $8.46B | |||
| Current Assets | $2.89B | $3.90B | $4.91B | $13.96B | $7.43B | |||
| Shortterm Investments Classified As Cash Equivalents | $0.00 | $11.0M | $200.0M | $668.0M | ||||
| Property Plant And Equipment | $153.0M | $137.0M | $142.0M | $237.0M | $162.0M | |||
| Noncurrent Receivables | $22.0M | $7.0M | $10.0M | $11.0M | $10.0M | |||
| Noncurrent Liabilities | $5.60B | $533.0M | $177.0M | $158.0M | $3.0M | |||
| Intangible Assets Other Than Goodwill | $9.12B | $1.73B | $15.0M | $470.0M | $470.0M | |||
| Current Liabilities | $1.43B | $744.0M | $368.0M | $938.0M | $444.0M | |||
| Other Current Payables | $1.07B | $489.0M | $342.0M | $839.0M | $316.0M | |||
| Net Deferred Tax Assets | $171.0M | $127.0M | $31.0M | $139.0M | $386.0M | |||
| Investment Accounted For Using Equity Method | $37.0M | $32.0M | $20.0M | $149.0M | ||||
| Other Noncurrent Payables | $5.0M | $5.0M | $5.0M | $1.0M | $2.0M | |||
| Ifrs Marketable Securities Current | $7.42B | $5.57B | ||||||
| Total Adjustments For Non Cash Transactions | $291.0M | $179.0M | $146.0M | |||||
| Purchase Of Interests In Investments Accounted For Using Equity Method | $4.0M | $8.0M | $4.0M | |||||
| Increase Decrease Through Net Settlement Of Restricted Stock Units Equity | -$9.0M | |||||||
| Purchase Of Intangible Assets Classified As Investing Activities | $18.0M | $17.0M | $1.0M | $32.0M | $406.0M | |||
| Current Tax Liabilities Current | $43.0M | $239.0M | $8.0M | $73.0M | $128.0M | |||
| Corporate Tax Receivable | $40.0M | $14.0M | $0.00 | |||||
| Increase Decrease Through Tax On Items Recognized Directly In Equity | $24.0M | $89.0M | $72.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method | $2.62B | $1.64B | $1.45B | $3.94B | $2.22B | $2.85B |
| Proceeds From Exercise Of Warrants | $23.0M | $19.0M | $21.0M | $65.0M | $75.0M | $215.0M |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $332.0M | -$887.0M | $797.0M | $3.00B | -$834.0M | $1.14B |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $3.0M | $63.0M | -$12.0M | $16.0M | $19.0M | -$95.0M |
| Payments Of Lease Liabilities Classified As Financing Activities | $13.0M | $9.0M | $14.0M | $31.0M | ||
| Increase Decrease In Working Capital | $1.22B | $634.0M | -$240.0M | |||
| Payments To Acquire Treasury Shares | 430.0M | 560.0M | 81.0M | 146.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $15.37 | $121.36 | $66.02 | $34.03 | $23.73 | $17.77 | ||||
| Basic Earnings Loss Per Share | $15.50 | $17.66 | $9.67 | $34.40 | $24.03 | $18.14 | ||||
| Number Of Shares Outstanding | 65.1M | 61.5M | 61.2M | 60.4M | 59.5M | 57.0M | 51.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expense | $2.66B | $2.15B | $1.62B | $2.73B | $1.65B | $1.02B | |||||
| Issued Capital | $64.0M | $10.0M | $66.0M | $66.0M | $65.1M | $61.0M | $61.2M | $60.4M | $59.6M | $57.0M | $51.8M |
| Finance Income | $408.0M | $645.0M | $299.0M | $228.0M | $243.0M | $72.0M | |||||
| Finance Costs | $269.0M | $291.0M | $254.0M | $7.0M | $11.0M | $352.0M | |||||
| Interest Received Classified As Operating Activities | $135.0M | $136.0M | $131.0M | $111.0M | $44.0M | $43.0M | |||||
| Increase Decrease Through Sharebased Payment Transactions | $124.0M | $105.0M | $85.0M | $147.0M | $91.0M | $76.0M | |||||
| Share Premium | $1.92B | $1.96B | $1.94B | $11.76B | $8.06B | ||||||
| Payment Of Withholding Taxes On Behalf Of Employees On Net Settled RS Us | $18.0M | $16.0M | $15.0M | $9.0M | |||||||
| Other Reserves | -$181.0M | -$226.0M | -$2.0M | $98.0M | $92.0M | ||||||
| Purchase Of Treasury Shares | 430.0M | 560.0M | 81.0M | 0.00 | 146.0M | 0.00 | |||||
| Reversal Of Financial Items Net | $221.0M | $232.0M | -$280.0M | ||||||||
| Interest Paid Classified As Operating Activities | $5.0M | $0.00 | $0.00 | $13.0M | $3.0M | ||||||
| Noncurrent Provisions | $2.0M | $1.0M | |||||||||
| Inventories | $18.0M | $9.0M | $8.0M |
Most recent annual filing with the SEC: February 17, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.